# Business Associate Agreement

**HIPAA Business Associate Agreement Template**

---

## BUSINESS ASSOCIATE AGREEMENT

This Business Associate Agreement ("Agreement") is entered into as of _________________ ("Effective Date") by and between:

**COVERED ENTITY:**
- Name: _________________________________
- Address: _________________________________
- ("Covered Entity")

**BUSINESS ASSOCIATE:**
- Name: Upstream Healthcare Platform, Inc.
- Address: _________________________________
- ("Business Associate")

Collectively referred to as the "Parties."

---

## RECITALS

WHEREAS, Covered Entity is a "covered entity" as defined by the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and its implementing regulations, including the Standards for Privacy of Individually Identifiable Health Information (the "Privacy Rule") and the Security Standards for the Protection of Electronic Protected Health Information (the "Security Rule") at 45 CFR Parts 160 and 164;

WHEREAS, Business Associate provides healthcare technology services that involve the creation, receipt, maintenance, or transmission of Protected Health Information ("PHI") on behalf of Covered Entity;

WHEREAS, the Parties wish to ensure compliance with HIPAA, the Health Information Technology for Economic and Clinical Health Act ("HITECH Act"), and all applicable federal and state regulations;

NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, the Parties agree as follows:

---

## ARTICLE 1: DEFINITIONS

### 1.1 HIPAA Definitions

All capitalized terms used but not otherwise defined in this Agreement shall have the meanings set forth in HIPAA, the HITECH Act, and their implementing regulations, including but not limited to:

- **"Breach"** means the acquisition, access, use, or disclosure of PHI in a manner not permitted under the Privacy Rule which compromises the security or privacy of the PHI, as defined in 45 CFR 164.402.

- **"Electronic Protected Health Information" or "ePHI"** means PHI that is transmitted by or maintained in electronic media, as defined in 45 CFR 160.103.

- **"Individual"** means the person who is the subject of the PHI, as defined in 45 CFR 160.103.

- **"Protected Health Information" or "PHI"** means individually identifiable health information, as defined in 45 CFR 160.103, that is created, received, maintained, or transmitted by Business Associate on behalf of Covered Entity.

- **"Required by Law"** has the meaning set forth in 45 CFR 164.103.

- **"Secretary"** means the Secretary of the U.S. Department of Health and Human Services.

- **"Security Incident"** means the attempted or successful unauthorized access, use, disclosure, modification, or destruction of information or interference with system operations in an information system, as defined in 45 CFR 164.304.

### 1.2 Additional Definitions

- **"AI/ML Services"** means artificial intelligence and machine learning capabilities provided by Business Associate, including but not limited to predictive analytics, natural language processing, and clinical decision support tools.

- **"De-identified Data"** means health information that does not identify an Individual and with respect to which there is no reasonable basis to believe that the information can be used to identify an Individual, in accordance with 45 CFR 164.514(a)-(c).

- **"Model Training"** means the process of using data to develop, train, validate, or improve machine learning algorithms or artificial intelligence models.

---

## ARTICLE 2: OBLIGATIONS OF BUSINESS ASSOCIATE

### 2.1 Permitted Uses and Disclosures

Business Associate agrees to use and disclose PHI only as follows:

**(a) Service Performance.** Business Associate may use or disclose PHI as necessary to perform functions, activities, or services for or on behalf of Covered Entity as specified in the underlying services agreement, provided such use or disclosure would not violate the Privacy Rule if done by Covered Entity.

**(b) Business Associate's Operations.** Business Associate may use PHI for the proper management and administration of Business Associate or to carry out legal responsibilities of Business Associate, provided that:
   - (i) The disclosures are Required by Law; or
   - (ii) Business Associate obtains reasonable assurances from the person to whom the information is disclosed that it will be held confidentially, used or further disclosed only as Required by Law or for the purpose for which it was disclosed, and that the person will notify Business Associate of any instances of which it becomes aware in which the confidentiality of the information has been breached.

**(c) Data Aggregation.** Business Associate may use PHI to provide Data Aggregation services to Covered Entity as permitted by 45 CFR 164.504(e)(2)(i)(B).

**(d) De-identification.** Business Associate may use PHI to create De-identified Data in accordance with 45 CFR 164.514(a)-(c), provided such De-identified Data may only be used as permitted under this Agreement and applicable law.

### 2.2 Prohibited Uses and Disclosures

Business Associate shall NOT:

**(a)** Use or disclose PHI other than as permitted or required by this Agreement or as Required by Law.

**(b)** Use or disclose PHI in a manner that would violate the Privacy Rule if done by Covered Entity.

**(c)** Sell PHI, as defined in 45 CFR 164.502(a)(5)(ii), without prior written authorization from both Covered Entity and the applicable Individual.

**(d)** Use or disclose PHI for marketing purposes without prior written authorization from both Covered Entity and the applicable Individual, except as permitted under 45 CFR 164.508(a)(3).

**(e)** Use or disclose genetic information for underwriting purposes, as defined in 45 CFR 164.502(a)(5)(i).

### 2.3 Safeguards

Business Associate shall:

**(a)** Implement administrative, physical, and technical safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of ePHI that it creates, receives, maintains, or transmits on behalf of Covered Entity, as required by the Security Rule.

**(b)** Ensure that any agent, including a subcontractor, to whom Business Associate provides PHI agrees in writing to the same restrictions and conditions that apply to Business Associate under this Agreement.

**(c)** Report to Covered Entity any use or disclosure of PHI not provided for by this Agreement of which Business Associate becomes aware, including any Security Incident or Breach.

### 2.4 Minimum Necessary

Business Associate shall limit its use, disclosure, or request of PHI to the minimum necessary to accomplish the intended purpose, in accordance with 45 CFR 164.502(b) and 164.514(d).

### 2.5 Individual Rights

Business Associate shall:

**(a) Access.** Make available PHI in a Designated Record Set to Covered Entity or, as directed by Covered Entity, to an Individual, within fifteen (15) business days of a request, to enable Covered Entity to fulfill its obligations under 45 CFR 164.524.

**(b) Amendment.** Make available PHI for amendment and incorporate any amendments to PHI in a Designated Record Set within fifteen (15) business days of receiving direction from Covered Entity, to enable Covered Entity to fulfill its obligations under 45 CFR 164.526.

**(c) Accounting of Disclosures.** Document and make available information required to provide an accounting of disclosures within thirty (30) days of a request, to enable Covered Entity to fulfill its obligations under 45 CFR 164.528.

**(d) Restrictions.** Comply with any agreed-upon restrictions on the use or disclosure of PHI as communicated by Covered Entity, in accordance with 45 CFR 164.522.

### 2.6 Documentation and Audit

**(a)** Business Associate shall maintain documentation of its policies, procedures, and practices sufficient to demonstrate compliance with this Agreement and HIPAA for a period of six (6) years from the date of creation or last effective date, whichever is later.

**(b)** Business Associate shall make its internal practices, books, and records relating to the use and disclosure of PHI available to the Secretary for purposes of determining Covered Entity's compliance with HIPAA.

**(c)** Upon reasonable notice, Business Associate shall make available to Covered Entity documentation demonstrating compliance with this Agreement, including security assessments, audit reports, and incident response documentation.

---

## ARTICLE 3: DATA USE LIMITATIONS

### 3.1 Primary Purpose Restriction

PHI shall be used by Business Associate solely for the purposes expressly authorized in the underlying services agreement and this Agreement. Any use of PHI beyond these authorized purposes requires prior written consent from Covered Entity.

### 3.2 Geographic Limitations

Unless otherwise agreed in writing by Covered Entity:

**(a)** All PHI shall be stored and processed within the United States.

**(b)** Business Associate shall not transfer PHI to any location outside the United States without prior written approval from Covered Entity.

**(c)** Business Associate shall ensure that all subcontractors processing PHI comply with these geographic restrictions.

### 3.3 Retention and Destruction

**(a)** Business Associate shall retain PHI only for as long as necessary to fulfill its obligations under the underlying services agreement or as Required by Law.

**(b)** Upon termination of this Agreement or the underlying services agreement, or upon request by Covered Entity, Business Associate shall:
   - (i) Return all PHI to Covered Entity in a format reasonably requested by Covered Entity; or
   - (ii) Destroy all PHI in accordance with NIST SP 800-88 guidelines for media sanitization, and certify such destruction in writing to Covered Entity within thirty (30) days.

**(c)** If return or destruction is not feasible, Business Associate shall extend the protections of this Agreement to such PHI and limit further uses and disclosures to those purposes that make the return or destruction infeasible.

### 3.4 Data Segregation

Business Associate shall implement appropriate technical and organizational measures to ensure that PHI belonging to Covered Entity is logically segregated from data belonging to other customers and from Business Associate's own data.

---

## ARTICLE 4: AI/ML-SPECIFIC PROVISIONS

### 4.1 Model Training Restrictions

**(a) No Training Without Authorization.** Business Associate shall NOT use PHI to train, develop, validate, or improve any machine learning models or artificial intelligence systems without prior written authorization from Covered Entity.

**(b) Authorized Training Requirements.** If Covered Entity authorizes the use of PHI for Model Training:
   - (i) Such authorization must be documented in writing and specify the scope, purpose, and duration of the authorized training activities.
   - (ii) Business Associate shall use De-identified Data or appropriately anonymized data for Model Training whenever feasible.
   - (iii) Business Associate shall implement privacy-preserving techniques such as differential privacy, federated learning, or secure multi-party computation when processing PHI for Model Training.
   - (iv) Models trained using PHI shall not be used for purposes outside of providing services to Covered Entity without explicit written consent.

**(c) Model Isolation.** Machine learning models trained on Covered Entity's PHI shall be logically isolated from models trained on other customers' data, unless Covered Entity provides explicit written consent for combined training approaches.

### 4.2 Explainability Requirements

**(a) Transparency.** Business Associate shall provide Covered Entity with documentation explaining:
   - (i) The general logic involved in any AI/ML-driven decisions or recommendations that affect Individuals' health information or care.
   - (ii) The data inputs used by AI/ML systems when processing PHI.
   - (iii) The factors that significantly contribute to AI/ML outputs related to Individuals.

**(b) Clinical Decision Support.** For AI/ML systems that provide clinical decision support or recommendations:
   - (i) Business Associate shall ensure that such systems are designed to support, not replace, clinical judgment by qualified healthcare providers.
   - (ii) Business Associate shall provide clear documentation of system limitations, intended use cases, and contraindications.
   - (iii) Business Associate shall implement mechanisms to allow clinicians to understand and, where appropriate, override AI/ML recommendations.

**(c) Bias Monitoring.** Business Associate shall:
   - (i) Implement processes to monitor AI/ML systems for potential bias in outcomes related to protected classes.
   - (ii) Provide Covered Entity with periodic reports on bias monitoring activities upon request.
   - (iii) Take prompt corrective action if significant bias is detected in AI/ML outputs.

### 4.3 Algorithmic Accountability

**(a)** Business Associate shall maintain records of AI/ML system versions, training data sources (in de-identified or aggregate form), and significant changes to algorithms that process PHI.

**(b)** Upon reasonable request, Business Associate shall provide Covered Entity with information necessary to respond to Individual inquiries about automated processing of their PHI.

**(c)** Business Associate shall notify Covered Entity of any material changes to AI/ML systems that process PHI at least thirty (30) days prior to implementation, unless such changes are necessary to address security vulnerabilities or legal requirements.

### 4.4 Human Oversight

**(a)** Business Associate shall ensure that AI/ML systems processing PHI include appropriate human oversight mechanisms.

**(b)** Fully automated decisions that significantly affect Individuals' health information or access to care shall include mechanisms for human review upon request.

---

## ARTICLE 5: BREACH NOTIFICATION

### 5.1 Discovery and Investigation

**(a)** Business Associate shall implement procedures to detect and investigate potential Breaches of PHI.

**(b)** A Breach shall be treated as discovered by Business Associate as of the first day on which such Breach is known to Business Associate or, by exercising reasonable diligence, would have been known to Business Associate.

### 5.2 Notification Requirements

**(a) Timing.** Business Associate shall notify Covered Entity of any Breach of Unsecured PHI without unreasonable delay and in no case later than **thirty (30) calendar days** after discovery of the Breach.

**(b) Content.** Notification shall include, to the extent known:
   - (i) Identification of each Individual whose Unsecured PHI has been, or is reasonably believed by Business Associate to have been, accessed, acquired, used, or disclosed during the Breach.
   - (ii) A description of the nature of the Breach, including the types of Unsecured PHI involved.
   - (iii) A description of what Business Associate is doing to investigate the Breach, mitigate harm to Individuals, and protect against further Breaches.
   - (iv) The date of the Breach and the date of discovery of the Breach, if known.
   - (v) Any other information required by 45 CFR 164.410.

**(c) Updates.** Business Associate shall provide supplemental information as it becomes available during the investigation.

### 5.3 Security Incidents

**(a)** Business Associate shall report to Covered Entity any Security Incident of which it becomes aware within **five (5) business days** of discovery.

**(b)** The Parties acknowledge that unsuccessful Security Incidents (such as routine network attacks, port scans, and unsuccessful login attempts) occur regularly. Business Associate shall provide aggregate reports of unsuccessful Security Incidents upon request by Covered Entity but is not required to report each unsuccessful incident individually.

### 5.4 Cooperation

**(a)** Business Associate shall cooperate with Covered Entity in investigating and responding to any Breach or Security Incident.

**(b)** Business Associate shall assist Covered Entity in meeting its obligations to notify affected Individuals and the Secretary, as required by 45 CFR 164.404 and 164.408.

**(c)** Business Associate shall preserve evidence related to any Breach or Security Incident for at least one (1) year following discovery.

### 5.5 HIPAA Breach Notification Timeline

Covered Entity acknowledges its obligation under HIPAA to notify affected Individuals and the Secretary within **sixty (60) calendar days** of discovery of a Breach. Business Associate's notification timeline under Section 5.2(a) is designed to enable Covered Entity to meet this requirement.

---

## ARTICLE 6: SUBCONTRACTORS

### 6.1 Subcontractor Requirements

**(a)** Business Associate shall not disclose PHI to any subcontractor or agent without first entering into a written agreement with such subcontractor or agent that contains substantially the same restrictions and conditions as this Agreement.

**(b)** Business Associate shall ensure that any subcontractor or agent agrees to implement reasonable and appropriate safeguards to protect PHI.

### 6.2 Subcontractor List

**(a)** Upon request, Business Associate shall provide Covered Entity with a list of subcontractors that have access to or process PHI on behalf of Covered Entity.

**(b)** Business Associate shall notify Covered Entity of any material changes to its subcontractor list within thirty (30) days.

### 6.3 Liability

Business Associate shall remain liable for the acts or omissions of its subcontractors and agents that receive PHI as if such acts or omissions were performed by Business Associate.

---

## ARTICLE 7: TERM AND TERMINATION

### 7.1 Term

This Agreement shall be effective as of the Effective Date and shall remain in effect until terminated as provided herein or upon termination of the underlying services agreement, whichever occurs first.

### 7.2 Termination for Cause

**(a)** Either Party may terminate this Agreement immediately upon written notice if the other Party materially breaches this Agreement and fails to cure such breach within thirty (30) days of receiving written notice of the breach.

**(b)** Covered Entity may terminate this Agreement immediately upon written notice if:
   - (i) Business Associate has breached a material term of this Agreement and cure is not possible; or
   - (ii) Business Associate has been found to be in violation of HIPAA by the Secretary.

### 7.3 Effect of Termination

**(a)** Upon termination of this Agreement, Business Associate shall:
   - (i) Cease all uses and disclosures of PHI not authorized by this Agreement or Required by Law.
   - (ii) Return or destroy all PHI in accordance with Section 3.3(b) of this Agreement.
   - (iii) Certify in writing to Covered Entity that all PHI has been returned or destroyed within thirty (30) days of termination.

**(b)** Obligations under this Agreement that by their nature should survive termination shall remain in effect, including but not limited to obligations regarding confidentiality, indemnification, and cooperation with regulatory investigations.

### 7.4 Automatic Termination

This Agreement shall automatically terminate upon termination of the underlying services agreement between the Parties, unless the Parties agree in writing to extend the Agreement for purposes of PHI return or destruction.

---

## ARTICLE 8: MISCELLANEOUS

### 8.1 Regulatory References

Any reference in this Agreement to a section of HIPAA, the HITECH Act, or their implementing regulations shall mean the section as in effect or as amended from time to time.

### 8.2 Amendment

This Agreement may only be amended by a written instrument signed by both Parties. The Parties agree to negotiate in good faith to amend this Agreement to comply with changes in HIPAA, the HITECH Act, or their implementing regulations.

### 8.3 Interpretation

This Agreement shall be interpreted in accordance with HIPAA, the HITECH Act, and their implementing regulations. Any ambiguity in this Agreement shall be resolved in favor of a meaning that permits the Parties to comply with HIPAA.

### 8.4 No Third-Party Beneficiaries

Nothing in this Agreement shall confer upon any person other than the Parties and their respective successors and permitted assigns any rights, remedies, obligations, or liabilities whatsoever.

### 8.5 Notices

All notices required or permitted under this Agreement shall be in writing and shall be deemed delivered when:
- (i) Delivered personally;
- (ii) Sent by confirmed email to the address specified by the receiving Party; or
- (iii) Three (3) business days after being sent by certified mail, return receipt requested, to the address set forth above or such other address as the Party may designate in writing.

### 8.6 Governing Law

This Agreement shall be governed by and construed in accordance with federal law, including HIPAA and the HITECH Act. To the extent federal law does not apply, this Agreement shall be governed by the laws of the state of _________________, without regard to its conflict of laws principles.

### 8.7 Entire Agreement

This Agreement, together with the underlying services agreement, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings, negotiations, and discussions, whether oral or written.

### 8.8 Severability

If any provision of this Agreement is found to be invalid or unenforceable, the remaining provisions shall remain in full force and effect, and the invalid or unenforceable provision shall be modified to the minimum extent necessary to make it valid and enforceable.

### 8.9 Counterparts

This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Electronic signatures shall be deemed valid and binding.

---

## SIGNATURES

**COVERED ENTITY:**

Signature: _________________________________

Name: _________________________________

Title: _________________________________

Date: _________________________________

**BUSINESS ASSOCIATE:**

Signature: _________________________________

Name: _________________________________

Title: _________________________________

Date: _________________________________

---

## EXHIBIT A: DESCRIPTION OF SERVICES

[Insert description of services provided by Business Associate that involve the use or disclosure of PHI]

---

## EXHIBIT B: PERMITTED USES AND DISCLOSURES

[Insert specific permitted uses and disclosures beyond those described in Article 2.1]

---

## EXHIBIT C: SECURITY SPECIFICATIONS

[Insert specific security requirements, certifications, and standards applicable to the services]

---

*This template is provided for informational purposes and should be reviewed by qualified legal counsel before use. Organizations should customize this template based on their specific requirements, services, and applicable state laws.*
